Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$772M |
| 2 |
Eli Lilly
LLY
|
+$337M |
| 3 |
lululemon athletica
LULU
|
+$301M |
| 4 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$297M |
| 5 |
ResMed
RMD
|
+$273M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$576M |
| 2 |
AT&T
T
|
+$476M |
| 3 |
PNC Financial Services
PNC
|
+$393M |
| 4 |
Fortive
FTV
|
+$389M |
| 5 |
Accenture
ACN
|
+$374M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 2.83% |
| 2 | Technology | 2.79% |
| 3 | Financials | 2.29% |
| 4 | Consumer Discretionary | 1.93% |
| 5 | Industrials | 1.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4051
Southland Holdings
SLND
$32.1M
| $4.14M | ﹤0.01% |
417,377
-450,083
| -52% | -$4.47M |
|
4052
PUT
Corpay
CPAY
$27.4B
| $4.14M | ﹤0.01% |
19,700
+1,000
| +5% | +$238K |
|
4053
Clearwater Paper
CLW
$345M
| $4.14M | ﹤0.01% |
123,026
+34,394
| +39% | +$1.08M |
|
4054
PUT
Nokia
NOK
$60.1B
| $4.14M | ﹤0.01% |
897,300
-156,200
| -15% | -$780K |
|
4055
CALL
ABM Industries
ABM
$2.82B
| $4.13M | ﹤0.01% |
95,200
+83,800
| +735% | +$3.88M |
|
|
PV
4056
DELISTED
Primavera Capital Acquisition Corporation
PV
| $4.13M | ﹤0.01% |
420,479
-350,041
| -45% | -$3.44M |
|
4057
CALL
Boot Barn
BOOT
$4.95B
| $4.13M | ﹤0.01% |
59,900
+5,100
| +9% | +$437K |
|
|
BLUE
4058
DELISTED
bluebird bio
BLUE
| $4.13M | ﹤0.01% |
49,819
+41,713
| +515% | +$3.23M |
|
4059
PUT
IMAX
IMAX
$2.9B
| $4.12M | ﹤0.01% |
244,100
+113,000
| +86% | +$1.84M |
|
4060
CALL
Gold Fields
GFI
$36B
| $4.12M | ﹤0.01% |
451,800
+114,800
| +34% | +$1.37M |
|
|
MZTI
4061
The Marzetti Company
MZTI
$3.18B
| $4.12M | ﹤0.01% |
31,971
+29,003
| +977% | +$3.97M |
|
|
WRK
4062
CALL
DELISTED
WestRock Company
WRK
| $4.12M | ﹤0.01% |
103,300
-70,500
| -41% | -$3.32M |
|
|
AL
4063
DELISTED
Air Lease Corp
AL
| $4.11M | ﹤0.01% |
122,949
+98,315
| +399% | +$3.73M |
|
4064
CALL
JFrog
FROG
$11.6B
| $4.11M | ﹤0.01% |
195,100
+91,300
| +88% | +$1.92M |
|
4065
BancFirst
BANF
$3.89B
| $4.11M | ﹤0.01% |
42,901
+19,543
| +84% | +$1.71M |
|
4066
Arcutis Biotherapeutics
ARQT
$3.29B
| $4.1M | ﹤0.01% |
192,511
+15,811
| +9% | +$324K |
|
4067
CALL
National Grid
NGG
$81.5B
| $4.1M | ﹤0.01% |
68,415
-37,081
| -35% | -$2.45M |
|
4068
ACI Worldwide
ACIW
$5.4B
| $4.1M | ﹤0.01% |
158,304
+41,639
| +36% | +$1.12M |
|
|
NPTN
4069
DELISTED
NEOPHOTONICS CORP
NPTN
| $4.1M | ﹤0.01% |
260,595
-19,112
| -7% | -$292K |
|
4070
Infosys
INFY
$49B
| $4.09M | ﹤0.01% |
221,203
+57,437
| +35% | +$1.14M |
|
|
OPLN
4071
Openlane
OPLN
$4.33B
| $4.09M | ﹤0.01% |
276,985
-36,797
| -12% | -$577K |
|
4072
CALL
Trane Technologies
TT
$106B
| $4.09M | ﹤0.01% |
31,500
-2,700
| -8% | -$373K |
|
4073
Benchmark Electronics
BHE
$2.94B
| $4.09M | ﹤0.01% |
181,102
+80,910
| +81% | +$1.95M |
|
|
CGC
4074
PUT
Canopy Growth
CGC
$431M
| $4.09M | ﹤0.01% |
143,360
+83,840
| +141% | +$4.36M |
|
|
SGI
4075
PUT
Somnigroup International
SGI
$13.9B
| $4.09M | ﹤0.01% |
191,200
+42,200
| +28% | +$1.09M |
|
Similar funds
Ken Griffin's Q2 2022 Portfolio in Review
As of Q2 2022, Ken Griffin held 14,957 positions worth $390B, down 20% from $484B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Ken Griffin's Q2 2022 filing shows 1,520 new, 5,503 increased, 5,522 reduced and 2,191 closed positions. Its largest new stake was ResMed: 1,280,595 shares worth $268M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $576M.
By sector, the portfolio is most concentrated in Healthcare at 2.8% of assets, up from 2.4% a quarter earlier, followed by Technology and Financials.
- Ken Griffin's largest Q2 2022 buy was ResMed: 1,280,595 shares worth $268M.
- Ken Griffin added most to Meta Platforms (Facebook) in Q2 2022, an estimated $772M increase.
- Ken Griffin's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $576M.
- Ken Griffin fully exited Vanguard Morningstar Small-Cap ETF in Q2 2022, selling an estimated $184M.
- Ken Griffin's ten largest holdings make up 28% of its $390B portfolio in Q2 2022.
- Ken Griffin opened 1,520 new positions and closed 2,191 in Q2 2022.
- Ken Griffin's portfolio value fell 20% quarter-over-quarter to $390B.
Based on Citadel Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.